ITGB1 and metabolic dysfunction-associated steatohepatitis: This study also revealed that EVs derived from hepatocytes enriched with ITGβ1, regulate NASH inflammation and that antibodies against ITGβ1 ameliorate NASH in diet-induced murine models of NASH, suggesting a potential anti-inflammatory therapeutic strategy for NASH [210].